[Insertion of mouse kappa light chain immunoglobulin gene sequences into a bacterial plasmid]

Annales D'Immunologie
|January 1, 1977
PubMed

Insights

Researchers created recombinant DNA from MOPC 173 tumor mRNA to study gene translocation. This method allows for the purification of immunoglobulin V and C genes from various cell types.

Area of Science:

  • Molecular Biology
  • Immunogenetics
  • Biotechnology

Background:

  • The MOPC 173 tumor produces 14S mRNA, a key component in immunoglobulin production.
  • Understanding gene structure and expression in tumors is crucial for cancer research.

Purpose of the Study:

  • To develop a method for creating recombinant DNA from tumor-derived mRNA.
  • To analyze the translocation of immunoglobulin variable (V) and constant (C) genes.
  • To enable the purification of V and C genes from germ line and tumor DNA.

Main Methods:

  • Transcription of 14S mRNA into cDNA using AMV DNA polymerase.
  • Conversion to double-stranded DNA using Escherichia coli DNA polymerase I.
  • Addition of oligo-dG tracts and hybridization to an E. coli plasmid (pCR1).
  • Transformation of E. coli cells and selection for kanamycin resistance.

Main Results:

  • Successful generation of recombinant DNA molecules containing V+C regions, or V or C regions alone.
  • Demonstration of GC base pairing for circular molecule formation.
  • Obtained several recombinant clones with specific immunoglobulin gene segments.

Conclusions:

  • The developed method is effective for creating recombinant DNA from tumor mRNA.
  • These recombinant molecules are valuable tools for studying immunoglobulin gene translocation.
  • The technique facilitates the purification of specific immunoglobulin genes from different cellular sources.